Nexplanon Manufacturer – All About Organon

David Fuller

Last Updated On: September 24, 2025

Behind every trusted medicine is a company dedicated to research, quality, and patient care. The global pharmaceutical market, now worth more than $1.4 trillion, depends on manufacturers who not only produce treatments but also uphold rigorous standards to keep them safe and effective.

One of those companies is Organon & Co., a global healthcare leader with a special focus on women’s health. Among its well-known products is Nexplanon, a small contraceptive implant that provides up to three years of reliable pregnancy prevention. By learning about the company behind this device, patients and providers gain a clearer view of the expertise and commitment driving its availability.

In this article, we’ll take a closer look at the Nexplanon manufacturer — Organon — exploring its history, mission, and lasting contributions to reproductive healthcare around the world.

Key Takeaways

• Organon is the global manufacturer of Nexplanon, with nearly a century of pharmaceutical expertise and a strong focus on women’s health.
• Nexplanon’s history began with Implanon in 1998, later refined under Merck and relaunched as Nexplanon before Organon became independent in 2021.
• The company’s reproductive health portfolio extends beyond Nexplanon, including products for contraception and fertility care.
• With approvals in 60+ countries and distribution in over 140 markets, Organon maintains global access while supporting safe use through provider education and post-marketing monitoring.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. If you’re looking to buy Nexplanon online, contact our sales department for more information.  

Overview of Organon as the Company Behind Nexplanon

Organon is the official manufacturer of Nexplanon, with roots tracing back to 1923 in the Netherlands. Over nearly a century, the company has built a strong reputation for innovation in pharmaceuticals, particularly in women’s health. Nexplanon is now one of its flagship reproductive health products and a major contributor to its women’s health portfolio.

Key points about Organon today:

• Headquarters: Jersey City, New Jersey
  
• Global Presence: Operating in 60+ countries, with products distributed in 140+ markets
  
• Mission: Addressing unmet healthcare needs, with a special focus on safe, effective solutions for women
  
• Core Areas: Women’s health, biosimilars, and established medicines across multiple therapeutic fields

Beyond Nexplanon, Organon continues to expand its reproductive health offerings, reflecting its commitment to supporting women across every stage of life.

How Organon Brought Nexplanon to Market

The journey of Nexplanon reflects decades of development and refinement:

• 1998: N.V. Organon (Netherlands) launches the original implant, Implanon, in Europe.
  
• Merck era: Under Merck’s ownership, the implant is updated with a radiopaque marker, improving safety by making the rod visible under imaging. It is rebranded as Nexplanon.
  
• 2009–2021: As part of Merck & Co., Nexplanon gains broader global distribution and regulatory approvals, including U.S. FDA clearance.
  
• 2021 and beyond: Organon becomes independent again, now fully focused on women’s health and directly overseeing Nexplanon’s global distribution.

Importantly, Organon continues to monitor product safety through both clinical studies and post-marketing surveillance, which document known Nexplanon side effects and provide ongoing reassurance to patients and providers.

Other Reproductive Health Products Developed by Organon

While Nexplanon is a cornerstone of Organon’s portfolio, the company also develops other products that reflect its mission to address women’s health comprehensively:

• NuvaRing®: A flexible vaginal ring that provides convenient, reliable contraception.
  
• Follistim AQ®: An injectable fertility treatment designed to support ovulation induction.
  
• Ganirelix Acetate Injection: Used during assisted reproductive technologies (ART) to regulate hormones.
  
• Crinone®: A progesterone gel used in fertility treatments.
  
• Implanon®: The predecessor to Nexplanon, still available in certain markets.

This range shows how Organon goes beyond contraception alone, addressing both birth control and fertility care to support women through different reproductive stages.

Global Reach and Distribution of Nexplanon by Organon

Today, Nexplanon is approved for use in more than 60 countries and trusted by millions of women worldwide. Organon oversees global manufacturing and distribution through its facilities and approved partners, maintaining consistent quality and availability. Its wide-scale presence allows the company to meet demand across both developed and developing markets.

Organon also supports education for healthcare providers to ensure safe insertion and removal of Nexplanon. Training initiatives and clear prescribing information help providers counsel patients accurately, improving both outcomes and satisfaction.

By maintaining a strong global distribution network, Organon expands access to long-acting reversible contraception (LARC) and strengthens women’s ability to make informed reproductive choices. Nexplanon’s availability across so many regions underscores Organon’s role as a trusted authority in contraception.

Conclusion

Organon has built a reputation as the definitive Nexplanon manufacturer. Its history of innovation, commitment to women’s health, and global scale highlight its dedication to improving reproductive care. Patients and providers can trust that Nexplanon is backed by a company with deep expertise and a clear mission to expand access to safe and effective contraceptives.

Through Nexplanon and a broad reproductive health portfolio, Organon continues to demonstrate leadership in advancing healthcare for women worldwide. Understanding the company behind the implant provides added confidence in both the product’s reliability and the values guiding its development.

FAQs

1. Who is the official Nexplanon manufacturer?

The official manufacturer is Organon, a global healthcare company with a strong focus on reproductive and women’s health solutions.

2. Who makes Nexplanon after Organon separated from Merck?

Since 2021, Organon has independently overseen the production and distribution of Nexplanon after its spin-off from Merck & Co.

3. What other products are part of Organon’s reproductive health?

Organon also makes NuvaRing, Follistim AQ, Ganirelix, and Crinone, along with fertility and contraceptive solutions beyond Nexplanon.

4. Where is Nexplanon manufactured and distributed?

Nexplanon is produced at approved facilities, including sites in the Netherlands, and distributed worldwide through Organon’s global supply network.

References

Mikulic M. Global pharmaceutical industry – statistics & facts. Statista. Published November 22, 2024. https://www.statista.com/topics/1764/global-pharmaceutical-industry/#topicOverview

Reed S, Minh TD, Lange JA, Koro C, Fox M, Heinemann K. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA). Contraception. 2019;100(1):31-36. doi:10.1016/j.contraception.2019.03.052

Palomba S, Falbo A, Di Cello A, Materazzo C, Zullo F. Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. Gynecological Endocrinology. 2012;28(9):710-721. doi:10.3109/09513590.2011.652247

About NEXPLANON. Organon PRO. https://organonpro.com/en-us/product/nexplanon/about-nexplanon/